Greenwoods Asset Management Hong Kong Ltd. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor acquired 165,459 shares of the semiconductor company’s stock, valued at approximately $81,636,000. Synopsys comprises approximately 1.8% of Greenwoods Asset Management Hong Kong Ltd.’s holdings, making the stock its 12th largest position.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Synopsys by 20.7% in the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after purchasing an additional 3,120,401 shares in the last quarter. Norges Bank bought a new position in shares of Synopsys during the 2nd quarter worth approximately $647,964,000. Ameriprise Financial Inc. grew its position in shares of Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after buying an additional 585,494 shares during the period. M&G PLC increased its stake in shares of Synopsys by 86,263.0% in the 3rd quarter. M&G PLC now owns 567,405 shares of the semiconductor company’s stock valued at $279,731,000 after acquiring an additional 566,748 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Synopsys by 177.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock valued at $427,269,000 after acquiring an additional 553,924 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Down 0.6%
SNPS opened at $439.94 on Friday. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The firm has a market capitalization of $84.17 billion, a P/E ratio of 55.06, a PEG ratio of 3.68 and a beta of 1.12. The company’s 50-day moving average is $474.06 and its 200 day moving average is $483.92. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the stock. Morgan Stanley raised their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Piper Sandler lowered Synopsys from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $602.00 to $520.00 in a report on Tuesday, January 13th. Finally, Needham & Company LLC raised their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $547.00.
Get Our Latest Analysis on SNPS
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Janet Lee sold 250 shares of the stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last quarter. 0.62% of the stock is owned by corporate insiders.
Key Stories Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
- Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
- Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
- Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
- Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
- Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
